Sana Biotechnology SANA Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's change in accrued liabilities?
- Sana Biotechnology (SANA) reported change in accrued liabilities of -$7.09M in Q1 2026.
- How has Sana Biotechnology's change in accrued liabilities changed year-over-year?
- Sana Biotechnology's change in accrued liabilities increased by 20.2% year-over-year, from -$8.89M to -$7.09M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.